Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
11/2010
11/04/2010CA2760271A1 Methods for the synthesis of amrubicin
11/03/2010EP2245024A1 5-hydroxy-2-methyl-4h-pyran-4-one-esters as novel tyrosinase inhibitors
11/03/2010EP2245003A2 Contrast agents
11/03/2010EP1242437B1 Novel stromelysin inhibitors
11/02/2010US7825265 di-aromatic compounds for treatment and prevention of diseases and disorders related to estrogen receptors; 2-fluoro-1-methoxy-4-(1-phenyl-cyclohexyl)-benzene
11/02/2010CA2389681C Npy y5 antagonist
10/2010
10/28/2010WO2010123016A1 Carboxylic acid compound
10/28/2010WO2010122968A1 Diacylethylenediamine compound
10/28/2010US20100274032 Method for preparing prostaglandin derivative
10/28/2010US20100274031 Methods for the synthesis of amrubicin
10/28/2010US20100274030 Cyclic ethers
10/28/2010US20100274029 Method of preparing (6r)-3-hexyl-4-hydroxy-6-undecyl-5, 6-dihydropyran-2-one, and intermediate used in the method
10/28/2010CA2759690A1 Carboxylic acid compound
10/28/2010CA2759264A1 Diacylethylenediamine compound
10/27/2010CN101874032A Novel naphthyridine derivative monohydrate and method for producing the same
10/26/2010CA2449192C Novel nitriles useful as reversible inhibitors of cysteine proteases
10/21/2010WO2010119161A2 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010US20100266717 Chemical and biological agents for the control of molluscs
10/21/2010CA2758852A1 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/20/2010EP2241561A1 Neuroprotective, hypocholesterolemic and antiepileptic compound
10/20/2010EP1569929B9 Compounds and methods for the treatment or prevention of flavivirus infections
10/20/2010CN101868439A Tetra- or penta-cyclic liquid crystalline compound having lateral fluorine, liquid crystal composition, and liquid crystal display element
10/20/2010CN101863766A Beta-hydroxyisovalerylshikonin derivative and preparation method thereof
10/19/2010US7816543 (2-Methylsulfanyl-ethyl)-amide of (2E,10E,12E,16Z,18E)-(R)-6-Hydroxy-3,5,7,9,11,15,17-heptamethyl-19-((2S,3S)-3-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)-8-oxo-nonadeca -2,10,12,16,18-pentaenoic acid; can conjugate to a cell binding reagent such as an antibody, display high target-specific cytotoxicity
10/19/2010CA2374631C Benzene derivatives, process for their preparation and pharmaceutical compositions containing them
10/14/2010CA2758233A1 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
10/13/2010EP2238122A1 Preparation of sulfamide derivatives
10/13/2010CN101200470B Cyclo c-glycosides compounds, c-glycosides intermediates as well as preparation method and uses thereof
10/13/2010CN101041650B Synthesizing of 3,5-dihydroxy-3-methyl valerolactone
10/12/2010US7812199 Hydroxyl compounds and compositions for cholesterol management and related uses
10/07/2010WO2010113813A1 Base-generating agent, photosensitive resin composition, patterning material comprising the photosensitive resin composition, patterning method and article using the photosensitive resin composition
10/07/2010US20100256400 Process for the preparation of renin inhibitors
10/06/2010EP2236137A1 Pharmaceutical composition for treatment of fatty liver diseases
10/06/2010EP2234954A1 Tetrasubstituted benzenes
10/06/2010CN101851244A Substituted phenyl keto enols as pesticides and herbicides
10/05/2010US7807703 Herbicides; pesticides
09/2010
09/30/2010WO2010110409A1 Process for producing pyrone and pyridone derivatives
09/30/2010US20100249167 Alkylsulfonyl-2,3-dihydrospiro[indene-1,4'-piperidine] analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
09/30/2010US20100249101 Malonamide derivatives with antithrombotic activity
09/29/2010EP2231633A1 Antitumoral compounds
09/29/2010EP2231145A2 Use of glycosylceramides for enhancing the immune response to antigens
09/29/2010CN101848903A Piperazine derivative having affinity for the histamine H3 receptor
09/29/2010CN101848899A N-benzyl, n' -arylcarbonylpiperazine derivatives as lxr modulators
09/29/2010CN101125837B C-glycosides type slycolipid compounds and use thereof
09/23/2010US20100237285 Cyclohexene compounds for liquid-crystalline mixtures
09/21/2010US7799828 selective estrogen receptor modulators such as 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene)methyl]benzoic acid, used for the treatment of osteoporosis, obesity, breast cancer, depression, vaginal dryness, rheumatoid arthritis, vasomotor symptoms and urogenital or vulvar vaginal atrophy
09/21/2010CA2401502C Carboxylic acid derivatives as ip antagonists
09/16/2010WO2010102848A1 Cyclopentadione derived herbicides
09/16/2010WO2010065865A3 Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
09/16/2010CA2750446A1 Cyclopentadione derived herbicides
09/15/2010EP1773284B1 Beta-substituted tetrahydropyran(on)s and method for the synthesis and their use in perfumery
09/15/2010CN101830876A C-aryl glucoside derivative, preparation method thereof and application thereof in medicine
09/15/2010CN101830843A Substituted heterocyclic compound and synthetic method thereof
09/14/2010US7795315 N-(2-amino-phenyl)-amide derivatives
09/14/2010US7795301 preventing myxoviruses infection using 3-(acetylamino)-2-{3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-1-[1,2-dihydroxyethyl]-19,20-dihydroxy-3,16-dioxo-2,17-dioxa-4,15-diazaicos-1-yl}-4-{[amino(imino)methyl]-amino}-3,4-dihydro-2H--pyran-6-carboxylic acid; viricides
09/14/2010CA2401757C Novel fatty acid analogues
09/14/2010CA2314771C Method for manufacturing aminoalcohol
09/10/2010WO2010102003A2 Alkylsulfonyl-2,3-dihydrospiro[indene-1,4'-piperidine] analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders
09/09/2010US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use
09/09/2010US20100226864 Alkyl-substituted tetrahydropyrans as flavoring substances
09/08/2010EP2225219A1 Method for producing cis-rose oxide
09/08/2010CN1819998B Optically active halohydrin derivative and process for producing optically active epoxy alcohol derivative from the same
09/07/2010US7790900 such as 1-amino-2-phenylpropane by reacting unsaturated nitroolefin with organosilicon compounds such as poly(methylhydrosiloxane) and phenylsilane, in presence of asymmetric copper complex having phosphine ligand
09/07/2010US7790764 Biologically active macrolides, compositions, and uses thereof
09/02/2010WO2010098583A2 Novel method for preparing statin compounds or salts thereof, and intermediate compounds used in same
09/02/2010WO2010097374A1 Compounds for use as bradykinin b1 antagonists
09/02/2010US20100222599 Processes for the preparation of sglt2 inhibitors
09/02/2010US20100222382 Esters of Compounds in the Leptomycin Family
09/01/2010EP2222657A1 4-phenylpyrane-3,5-diones, 4-phenylthiopyrane-3,5-diones and 2-phenylcyclohexane-1,3,5-triones as herbicides
09/01/2010EP1555261B1 Valerolactone compounds and perfume composition
09/01/2010CN101821258A Novel preparation process
08/2010
08/31/2010US7786316 Metalloprotein inhibitors
08/26/2010WO2010095768A1 4 -isopropylphenyl glucitol compounds as sgltl inhibitors
08/26/2010WO2010095506A1 Tetracyclic liquid-crystalline compound having tetrahydropyran and 2,2',3,3'-tetrafluorobiphenyl, liquid-crystal composition, and liquid-crystal display element
08/26/2010US20100216915 Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents
08/26/2010US20100216873 5-Hydroxy-2-Methyl-4H-Pyran-4-One Esters as Novel Tyrosinase Inhibitors
08/26/2010US20100216072 Positive photosensitive composition, pattern forming method using the composition and resin for use in the composition
08/26/2010CA2752807A1 Amine or amino alcohols as glyt1 inhibitors
08/26/2010CA2752212A1 4-isopropylphenyl glucitol compounds as sgltl inhibitors
08/25/2010EP2221309A1 Novel naphthyridine derivative monohydrate and method for producing the same
08/25/2010EP2220041A1 Synthesis of quaternary salt compounds
08/25/2010CN101812043A C-aryl glucoside derivative, preparation method thereof and application thereof in medicine
08/25/2010CN101289440B Polyene macrocyclic compounds, preparation thereof and applications
08/24/2010US7781601 Method for the production of 6,6,6-trihalo-3,5-dioxohexanoic acid esters
08/19/2010WO2010093706A2 Chemically programmed vaccination
08/19/2010WO2010092154A1 Novel substituted indanes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010092153A1 New substituted tetrahydronapthalenes, method for the production thereof, and use thereof as drugs
08/19/2010WO2010075280A3 Coumarin-based compounds for the treatment of alzheimer's disease and cancer
08/18/2010EP2217565A1 Compounds which modulate the cb2 receptor
08/17/2010US7777056 from the corresponding 3,5-dihydroxy pentanoic acid derivative; in the absence or presence of orthophosphoric acid or its alkali dihydrogen salts or alkali hydrogen salts of a dibasic acid, followed by optional neutralization of the reaction mixture with an organic base
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776884 Cyclic derivatives as modulators of chemokine receptors activity
08/17/2010CA2370412C Pharmaceutical compounds
08/12/2010WO2010090305A1 Substituted acylguanidine derivative
08/12/2010WO2010090304A1 Acylguanidine derivative
08/12/2010WO2010089211A1 Novel herbicides
08/12/2010WO2010089210A1 Novel herbicides
08/12/2010US20100204491 Method for preparing prostaglandin derivative
08/12/2010US20100204489 Method for preparing prostaglandin derivative
08/12/2010US20100204356 Polyurethanes, polyureas, and process for their production
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 ... 129